Acefylline

Acefylline
Clinical data
Routes of; administration	Intramuscular, Intravenous
ATC code	R03DA09 (WHO) (acefylline piperazine);
Identifiers
	IUPAC name (1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)acetic acid;
CAS Number	652-37-9 ;
PubChem CID	69550;
ChemSpider	62754 ;
UNII	M494UE2YEP;
ChEMBL	ChEMBL70246 ;
CompTox Dashboard (EPA)	DTXSID6057796 ;
ECHA InfoCard	100.010.447
Chemical and physical data
Formula	C9H10N4O4
Molar mass	238.203 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C2N(c1ncn(c1C(=O)N2C)CC(=O)O)C;
	InChI InChI=1S/C9H10N4O4/c1-11-7-6(8(16)12(2)9(11)17)13(4-10-7)3-5(14)15/h4H,3H2,1-2H3,(H,14,15) ; Key:HCYFGRCYSCXKNQ-UHFFFAOYSA-N ;
	(verify)

Acefylline (INN),^[1] also known as 7-theophyllineacetic acid, is a stimulant drug of the xanthine chemical class. It acts as an adenosine receptor antagonist. It is combined with diphenhydramine in the pharmaceutical preparation etanautine to help offset diphenhydramine induced drowsiness.^[2]

A silanol–mannuronic acid conjugate of acefylline, acefylline methylsilanol mannuronate (INCI; trade name Xantalgosil C) is marketed as a lipolytic phosphodiesterase inhibitor. It is used as an ingredient in cosmeceuticals for the treatment of cellulite and as a skin conditioner.^[3]^[4]

References

^ "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 21" (PDF). World Health Organization. Retrieved 29 December 2016.
^ Zuidema J (1978). "Biofarmaceutische en farmacokinetische aspecten van theofylline en acefylline". Thesis (doctoral)--Universiteit van Amsterdam. Archived from the original on 2016-12-30. Retrieved 2012-09-29. {{cite journal}}: Cite journal requires |journal= (help)
^ Biosil Technologies (2005). "Xantalgosil C® Datasheet" (PDF). Exsymol S.A.M. Retrieved 2022-01-20.
^ Winter, Ruth (2009-10-20). A Consumer's Dictionary of Cosmetic Ingredients (7th ed.). Harmony/Rodale. p. 42. ISBN 9780307459862.

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

Zdroj:https://en.wikipedia.org?pojem=Acefylline
Text je dostupný za podmienok Creative Commons Attribution/Share-Alike License 3.0 Unported; prípadne za ďalších podmienok. Podrobnejšie informácie nájdete na stránke Podmienky použitia.

[INN-1] "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names (Rec. INN): List 21" (PDF). World Health Organization. Retrieved 29 December 2016.

[2] Zuidema J (1978). "Biofarmaceutische en farmacokinetische aspecten van theofylline en acefylline". Thesis (doctoral)--Universiteit van Amsterdam. Archived from the original on 2016-12-30. Retrieved 2012-09-29. {{cite journal}}: Cite journal requires |journal= (help)

[3] Biosil Technologies (2005). "Xantalgosil C® Datasheet" (PDF). Exsymol S.A.M. Retrieved 2022-01-20.

[4] Winter, Ruth (2009-10-20). A Consumer's Dictionary of Cosmetic Ingredients (7th ed.). Harmony/Rodale. p. 42. ISBN 9780307459862.

[1]

[2]

[3]

[4]

Clinical data


Routes of administration	Intramuscular, Intravenous
ATC code	R03DA09 (WHO) (acefylline piperazine)
Identifiers
IUPAC name (1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)acetic acid
CAS Number	652-37-9^N
PubChem CID	69550
ChemSpider	62754^Y
UNII	M494UE2YEP
ChEMBL	ChEMBL70246^Y
CompTox Dashboard (EPA)	DTXSID6057796
ECHA InfoCard	100.010.447
Chemical and physical data
Formula	C₉H₁₀N₄O₄
Molar mass	238.203 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES O=C2N(c1ncn(c1C(=O)N2C)CC(=O)O)C
InChI InChI=1S/C9H10N4O4/c1-11-7-6(8(16)12(2)9(11)17)13(4-10-7)3-5(14)15/h4H,3H2,1-2H3,(H,14,15)^Y Key:HCYFGRCYSCXKNQ-UHFFFAOYSA-N^Y
(verify)

See also

References